No Prescription |
 |
 | ||
|
Evalon Ovestin |
|
| ||
No Prescription » Prescription Drugs 7 » Evalon Ovestin Evalon used in the treatment of vaginal complaints such as dyspareunia dryness and itching. Evalon used for the prevention of recurrent infections of the vagina and lower urinary tract. Evalon used in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence.Pre- and post-operative therapy in postmenopausal women undergoing vaginal surgery. Buy Evalon Ovestin and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About Evalon Ovestin: Product Type: Prescription Drugs 7 Evalon ( Ovestin Generic Estradiol ) Evalon (Ovestin Generic Estradiol) Ovestin Generic Estradiol 1mg 30 Tablets 90(3 x 30) Tablets Ovestin Generic Estradiol Evalon
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
